Ireland: Thinking Of Ireland Post-Brexit?

Last Updated: 28 July 2016
Article by Michael Finn and Joe Duffy

Making it Easy for Life Sciences Companies doing Business in and from Ireland

In the post-Brexit climate, Ireland's position as an English speaking gateway to one of the world's largest markets will be even more significant than in the past. Given Ireland's proximity to one of the world's largest markets, it is plausible that life sciences and medtech companies may move or plan to move some or all of their operations or business lines to Ireland in order to retain access to the European market.

Ireland's existing infrastructure for life sciences and medtech companies bolsters this attraction. Ireland is already the largest net exporter of pharmaceuticals in the world. 18 of the world's top 20 pharmaceutical companies have substantial operations in Ireland and 6 of the world's top 10 selling pharmaceutical products are exclusively produced here. Ireland has also one of Europe's leading medtech sectors, with 13 of the world's top 15 medtech companies having operations here. A central feature of the evolution and growth in this sector is the productive collaboration between industry, academia and government agencies, which facilitates the ease by which life sciences companies can do business in and from Ireland.

Establishment / Start up

IDA Ireland is the Irish Government enterprise agency responsible for securing foreign direct investment for Ireland. Enterprise Ireland is the Irish government agency responsible for the development and promotion of Irish enterprise. These bodies provide significant support programmes for life sciences companies seeking to establish operations in Ireland.

Enterprise Ireland's 'High Potential Start-Up' team provides hands-on support and advice to entrepreneurs and early stage companies that are considered by Enterprise Ireland to have an innovative product, service or technology, and have the potential to achieve international sales and create employment. It also operates a national incubation programme, called the 'New Frontiers Entrepreneur Development Programme' which offers a package of supports to help accelerate business growth and equip individuals with the skills to start and grow their company.

InterTradeIreland, a cross-border trade and business development body jointly funded by the Irish and Northern Ireland governments, runs a programme called 'Elevate' to assist with sales development by providing financial or mentoring assistance to help identify cross-border markets or customers, and win new business throughout Ireland and Northern Ireland. On a broader scale, the Enterprise Europe Network assists SMEs who are looking for EU programmes and supports. It organises international brokerage events and provides a central database for SMEs to offer, or search for, business opportunities, technology transfer and licensing deals in the EU and in many other countries.

Funding Support

There are a number of funding supports available for life science companies establishing in Ireland and conducting business in and from Ireland. For example, InterTradeIreland provides funding advice for early stage companies and established businesses giving companies the opportunity to meet with a corporate finance expert to discuss their funding requirements and consider how new funding can help their business grow. InterTradeIreland also operates a programme called 'Acumen', which assists companies grow their business on an all-island basis by targeting new cross-border markets and providing funding for market research or hiring sales staff.

The Dublin Business Innovation Centre runs the 'Halo Business Angel Network' which connects private investors with investment opportunities in start-up or early stage companies. Enterprise Ireland also operates a 'Competitive Start Fund' which operates to accelerate the growth of start-up companies that have the capability to succeed in global markets and the 'Innovative HPSU Fund (Equity)' which offers equity investment to high potential start-up clients to support the implementation of company business plans.

Finance and Tax Incentives

In addition to the attractive low Irish corporation tax rate of 12.5%, there are a number of further Irish tax incentives for emerging and existing life sciences companies in Ireland, including:

  • a 25% tax credit for qualifying R&D expenditure carried on within the EEA. This tax credit is in addition to the normal business deduction for such R&D expenditure (at the 12.5% rate), thus incentivising expenditure on R&D at an effective rate of 37.5%. These credits may also be surrendered to key employees actively involved in R&D activities, thereby reducing the effective rate of Irish income tax for such employees.
  • a best in class 'knowledge development box' which complies with the OECD's 'modified nexus' standard. This incentive reduces the rate of Irish corporation tax to 6.25% for profits derived from certain IP assets, where qualifying R&D activity is carried on in Ireland. This incentive can also be claimed in conjunction with the R&D tax credit.
  • tax depreciation for certain intangible assets. Such assets can be 'amortised' for Irish corporation tax purposes in line with their accounting treatment or alternatively on a straight basis over 15 years.
  • the Employment and Investment Incentive (EII) and Start-up Refunds for Entrepreneurs (SURE) schemes which allow individual investors in life sciences companies to obtain Irish income tax relief (of up to 41%) on investments made, in each tax year, into certified qualifying companies. Relief is available in respect of funding of up to €10 million.

Employment

Skillnets is a government funded body which runs a 'Training Networks Programme' which provides subsidised and relevant training for companies. There are also a number of employer incentivised employment schemes run by the Department of Social Protection, such as 'JobsPlus' and 'JobBridge'.

Research, Development and Innovation

Science Foundation Ireland is the national foundation for investment in scientific and engineering research. It funds oriented basic and applied research in the areas of science, technology, engineering and mathematics in order to promote and assist the development and competitiveness of industry, enterprise and employment in Ireland. For example, it operates an 'Industry Fellowships' programme which enables staff and postdoctoral academic researchers based in Ireland to spend time in industry worldwide and individuals from industry based anywhere in the world to spend time in an eligible Irish academic or research institution.

'Fusion' is InterTradeIreland's all-island technology transfer programme, which links companies up with third-level institutions providing them with the specialist expertise of a high calibre graduate working directly in the organisation to deliver a new product or process improvement project.

Enterprise Ireland runs the 'Innovation Partnership Grant Programme' which provides financial support to companies who engage in collaborative research projects with Irish universities or Institutes of Technology.

In addition, the Irish Government has provided funding to establish industry-led 'Technology Centres', coordinated by Enterprise Ireland, IDA Ireland and Science Foundation Ireland. These centres are resourced by highly qualified researchers undertaking market focused strategic research and development for the benefit of industry.

Conclusion

These are just some of the numerous support programmes and incentives available for life sciences companies doing business in and from Ireland. The level of support and collaboration for start-up, emerging or expanding companies and the level of support and collaboration between industry, academia and the Irish Government makes Ireland one of the most attractive places for pharmaceutical and medtech companies to conduct their business.

This article first appeared in the Business and Finance Life Sciences 50 edition.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions